Corporate Profile

CURE Pharmaceutical is a fully integrated life science company with a proprietary platform of dosage forms and delivery systems for a broad range of molecules. As a preeminent developer and manufacturer of the most advanced oral thin film (OTF) on the market today with an industry leading full service cGMP manufacturer, CURE is on a mission to make medications easier to take, more efficacious, and with fewer tolerability and side effects. CURE offers the most advanced development and manufacturing of nutraceuticals, OTC products, pharmaceuticals, and veterinary medicants in a patented, proprietary, OTF delivery system. Alongside its stand-alone OTF technology, CURE has developed an array of products in cutting-edge delivery platforms such as, sublingual and transdermal applications. Collectively CURE brings over 90 years of experience formulating and manufacturing nutraceuticals, OTC products, pharmaceuticals, and veterinary medications placing quality and service as our top priorities, thus earning us the trust and respect of customers worldwide.

Corporate HQ, Receiving, & Manufacturing
1620 Beacon Place
Oxnard, CA 93033
Phone: 1-805-824-0410
Fax: 1-805-487-7163

Michael Bayes
Liviakis Financial Communications, Inc.
655 Redwood Hwy., Suite 395
Mill Valley, CA 94941
1-415-389-4670 Office
[email protected]

Stock Performance

Market Data copyright © 2018 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

Management Team

  • Robert Davidson - CEO and Chairman of the Board of Directors

  • Edward Maliski, PhD - President and Chief Science Officer

  • Jessica Rousset - Chief Operating Officer

  • Mark Udell - Chief Financial Officer

  • Vered Gigi, PhD - VP of Strategy and Business Development

  • Steven Ruhl - VP of Manufacturing

Board of Directors

  • William Yuan - Director

  • Charles Berman - Director

  • Alan Einstein, MD - Director